Skip to main content
. 2024 Apr 1;221(5):e20231044. doi: 10.1084/jem.20231044

Table 2.

Serological data for patients with AR CD4 deficiency

Patient Mutation HSV-1 (>1.1) HSV-2 (>1.1) CMV (>14) EBV (>20) VZV (>135) Measles (>16.5) Mumps (>11) Rubella (>10) B19 (>1.1) Anti-HBs Ab (>10) HCV (>1) HAV (>1) HIV (>1) Others Age at sampling (years)
P1 c.491delA/491delA Neg Neg 155 100 (VCA) Neg 18 51 Neg Neg 47 Neg Neg Neg 13
P2 p.S82*/S82* 34 Neg 116 Neg 1960 ND ND ND 3 Neg Neg Neg Neg 52
P3 p.S82*/S82* 44 Neg Neg Neg 1070 274 36 137 Neg Neg Neg 9 Neg 50
P4 p.R79C/R79C 1.4 Neg >180 152 Neg >300 133 185 Neg 473 Neg Neg Neg 5
P5 p.R79C/p. R79C 46 Neg 175 55 1740 Neg Neg 28 28 Neg Neg Neg Neg 22
P6 c.1A>G/c.1A>G ND ND ND ND Pos Pos Neg Pos ND Neg ND Neg Neg 23
P7 c.1157-1 G>A/c.1157-1 G>A ND ND >250 >192 (VCA) ND ND ND ND ND ND ND ND Neg 45

Ag, antigens; B19, parvovirus B19; CMV, cytomegalovirus; DT, doubtful result; EBV, Epstein–Barr virus; HAV, hepatitis A virus; HBs, hepatitis B surface Ag; HSV, herpes simplex virus; ND, not determined; VZV, varicella-zoster virus; −, uninfected with other known pathogens.